Global Cancer Drug based on CAR-T Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Cancer Drug based on CAR-T market size was valued at US$ 618.3 million in 2023. With growing demand in downstream market, the Cancer Drug based on CAR-T is forecast to a readjusted size of US$ 880.8 million by 2030 with a CAGR of 5.2% during review period.
The research report highlights the growth potential of the global Cancer Drug based on CAR-T market. Cancer Drug based on CAR-T are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Cancer Drug based on CAR-T. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Cancer Drug based on CAR-T market.
A type of treatment in which a patient's T cells (a type of immune system cell) are changed in the laboratory so they will attack cancer cells. T cells are taken from a patient’s blood. Then the gene for a special receptor that binds to a certain protein on the patient’s cancer cells is added to the T cells in the laboratory. The special receptor is called a chimeric antigen receptor (CAR). Large numbers of the CAR T cells are grown in the laboratory and given to the patient by infusion. CAR T-cell therapy is used to treat certain blood cancers, and it is being studied in the treatment of other types of cancer. Also called chimeric antigen receptor T-cell therapy.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Cancer Drug based on CAR-T market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Cancer Drug based on CAR-T market. It may include historical data, market segmentation by Type (e.g., Allogeneic, Autologous), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Cancer Drug based on CAR-T market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Cancer Drug based on CAR-T market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Cancer Drug based on CAR-T industry. This include advancements in Cancer Drug based on CAR-T technology, Cancer Drug based on CAR-T new entrants, Cancer Drug based on CAR-T new investment, and other innovations that are shaping the future of Cancer Drug based on CAR-T.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Cancer Drug based on CAR-T market. It includes factors influencing customer ' purchasing decisions, preferences for Cancer Drug based on CAR-T product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Cancer Drug based on CAR-T market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Cancer Drug based on CAR-T market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Cancer Drug based on CAR-T market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Cancer Drug based on CAR-T industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Cancer Drug based on CAR-T market.
Market Segmentation:
Cancer Drug based on CAR-T market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
According to our LPI (LP Information) latest study, the global Cancer Drug based on CAR-T market size was valued at US$ 618.3 million in 2023. With growing demand in downstream market, the Cancer Drug based on CAR-T is forecast to a readjusted size of US$ 880.8 million by 2030 with a CAGR of 5.2% during review period.
The research report highlights the growth potential of the global Cancer Drug based on CAR-T market. Cancer Drug based on CAR-T are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Cancer Drug based on CAR-T. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Cancer Drug based on CAR-T market.
A type of treatment in which a patient's T cells (a type of immune system cell) are changed in the laboratory so they will attack cancer cells. T cells are taken from a patient’s blood. Then the gene for a special receptor that binds to a certain protein on the patient’s cancer cells is added to the T cells in the laboratory. The special receptor is called a chimeric antigen receptor (CAR). Large numbers of the CAR T cells are grown in the laboratory and given to the patient by infusion. CAR T-cell therapy is used to treat certain blood cancers, and it is being studied in the treatment of other types of cancer. Also called chimeric antigen receptor T-cell therapy.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Cancer Drug based on CAR-T market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Cancer Drug based on CAR-T market. It may include historical data, market segmentation by Type (e.g., Allogeneic, Autologous), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Cancer Drug based on CAR-T market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Cancer Drug based on CAR-T market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Cancer Drug based on CAR-T industry. This include advancements in Cancer Drug based on CAR-T technology, Cancer Drug based on CAR-T new entrants, Cancer Drug based on CAR-T new investment, and other innovations that are shaping the future of Cancer Drug based on CAR-T.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Cancer Drug based on CAR-T market. It includes factors influencing customer ' purchasing decisions, preferences for Cancer Drug based on CAR-T product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Cancer Drug based on CAR-T market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Cancer Drug based on CAR-T market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Cancer Drug based on CAR-T market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Cancer Drug based on CAR-T industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Cancer Drug based on CAR-T market.
Market Segmentation:
Cancer Drug based on CAR-T market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
- Allogeneic
- Autologous
- Hospital
- Pharmacy
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Fosun Kite Biotechnology
- Gilead Sciences
- Novartis
- Bristol-Myers Squibb
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Cancer Drug based on CAR-T Market Size 2019-2030
2.1.2 Cancer Drug based on CAR-T Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Cancer Drug based on CAR-T Segment by Type
2.2.1 Allogeneic
2.2.2 Autologous
2.3 Cancer Drug based on CAR-T Market Size by Type
2.3.1 Cancer Drug based on CAR-T Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Cancer Drug based on CAR-T Market Size Market Share by Type (2019-2024)
2.4 Cancer Drug based on CAR-T Segment by Application
2.4.1 Hospital
2.4.2 Pharmacy
2.4.3 Other
2.5 Cancer Drug based on CAR-T Market Size by Application
2.5.1 Cancer Drug based on CAR-T Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Cancer Drug based on CAR-T Market Size Market Share by Application (2019-2024)
3 CANCER DRUG BASED ON CAR-T MARKET SIZE BY PLAYER
3.1 Cancer Drug based on CAR-T Market Size Market Share by Players
3.1.1 Global Cancer Drug based on CAR-T Revenue by Players (2019-2024)
3.1.2 Global Cancer Drug based on CAR-T Revenue Market Share by Players (2019-2024)
3.2 Global Cancer Drug based on CAR-T Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CANCER DRUG BASED ON CAR-T BY REGIONS
4.1 Cancer Drug based on CAR-T Market Size by Regions (2019-2024)
4.2 Americas Cancer Drug based on CAR-T Market Size Growth (2019-2024)
4.3 APAC Cancer Drug based on CAR-T Market Size Growth (2019-2024)
4.4 Europe Cancer Drug based on CAR-T Market Size Growth (2019-2024)
4.5 Middle East & Africa Cancer Drug based on CAR-T Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Cancer Drug based on CAR-T Market Size by Country (2019-2024)
5.2 Americas Cancer Drug based on CAR-T Market Size by Type (2019-2024)
5.3 Americas Cancer Drug based on CAR-T Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cancer Drug based on CAR-T Market Size by Region (2019-2024)
6.2 APAC Cancer Drug based on CAR-T Market Size by Type (2019-2024)
6.3 APAC Cancer Drug based on CAR-T Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Cancer Drug based on CAR-T by Country (2019-2024)
7.2 Europe Cancer Drug based on CAR-T Market Size by Type (2019-2024)
7.3 Europe Cancer Drug based on CAR-T Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Cancer Drug based on CAR-T by Region (2019-2024)
8.2 Middle East & Africa Cancer Drug based on CAR-T Market Size by Type (2019-2024)
8.3 Middle East & Africa Cancer Drug based on CAR-T Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL CANCER DRUG BASED ON CAR-T MARKET FORECAST
10.1 Global Cancer Drug based on CAR-T Forecast by Regions (2025-2030)
10.1.1 Global Cancer Drug based on CAR-T Forecast by Regions (2025-2030)
10.1.2 Americas Cancer Drug based on CAR-T Forecast
10.1.3 APAC Cancer Drug based on CAR-T Forecast
10.1.4 Europe Cancer Drug based on CAR-T Forecast
10.1.5 Middle East & Africa Cancer Drug based on CAR-T Forecast
10.2 Americas Cancer Drug based on CAR-T Forecast by Country (2025-2030)
10.2.1 United States Cancer Drug based on CAR-T Market Forecast
10.2.2 Canada Cancer Drug based on CAR-T Market Forecast
10.2.3 Mexico Cancer Drug based on CAR-T Market Forecast
10.2.4 Brazil Cancer Drug based on CAR-T Market Forecast
10.3 APAC Cancer Drug based on CAR-T Forecast by Region (2025-2030)
10.3.1 China Cancer Drug based on CAR-T Market Forecast
10.3.2 Japan Cancer Drug based on CAR-T Market Forecast
10.3.3 Korea Cancer Drug based on CAR-T Market Forecast
10.3.4 Southeast Asia Cancer Drug based on CAR-T Market Forecast
10.3.5 India Cancer Drug based on CAR-T Market Forecast
10.3.6 Australia Cancer Drug based on CAR-T Market Forecast
10.4 Europe Cancer Drug based on CAR-T Forecast by Country (2025-2030)
10.4.1 Germany Cancer Drug based on CAR-T Market Forecast
10.4.2 France Cancer Drug based on CAR-T Market Forecast
10.4.3 UK Cancer Drug based on CAR-T Market Forecast
10.4.4 Italy Cancer Drug based on CAR-T Market Forecast
10.4.5 Russia Cancer Drug based on CAR-T Market Forecast
10.5 Middle East & Africa Cancer Drug based on CAR-T Forecast by Region (2025-2030)
10.5.1 Egypt Cancer Drug based on CAR-T Market Forecast
10.5.2 South Africa Cancer Drug based on CAR-T Market Forecast
10.5.3 Israel Cancer Drug based on CAR-T Market Forecast
10.5.4 Turkey Cancer Drug based on CAR-T Market Forecast
10.5.5 GCC Countries Cancer Drug based on CAR-T Market Forecast
10.6 Global Cancer Drug based on CAR-T Forecast by Type (2025-2030)
10.7 Global Cancer Drug based on CAR-T Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Fosun Kite Biotechnology
11.1.1 Fosun Kite Biotechnology Company Information
11.1.2 Fosun Kite Biotechnology Cancer Drug based on CAR-T Product Offered
11.1.3 Fosun Kite Biotechnology Cancer Drug based on CAR-T Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Fosun Kite Biotechnology Main Business Overview
11.1.5 Fosun Kite Biotechnology Latest Developments
11.2 Gilead Sciences
11.2.1 Gilead Sciences Company Information
11.2.2 Gilead Sciences Cancer Drug based on CAR-T Product Offered
11.2.3 Gilead Sciences Cancer Drug based on CAR-T Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Gilead Sciences Main Business Overview
11.2.5 Gilead Sciences Latest Developments
11.3 Novartis
11.3.1 Novartis Company Information
11.3.2 Novartis Cancer Drug based on CAR-T Product Offered
11.3.3 Novartis Cancer Drug based on CAR-T Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Novartis Main Business Overview
11.3.5 Novartis Latest Developments
11.4 Bristol-Myers Squibb
11.4.1 Bristol-Myers Squibb Company Information
11.4.2 Bristol-Myers Squibb Cancer Drug based on CAR-T Product Offered
11.4.3 Bristol-Myers Squibb Cancer Drug based on CAR-T Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Bristol-Myers Squibb Main Business Overview
11.4.5 Bristol-Myers Squibb Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Cancer Drug based on CAR-T Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Allogeneic
Table 3. Major Players of Autologous
Table 4. Cancer Drug based on CAR-T Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 5. Global Cancer Drug based on CAR-T Market Size by Type (2019-2024) & ($ Millions)
Table 6. Global Cancer Drug based on CAR-T Market Size Market Share by Type (2019-2024)
Table 7. Cancer Drug based on CAR-T Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global Cancer Drug based on CAR-T Market Size by Application (2019-2024) & ($ Millions)
Table 9. Global Cancer Drug based on CAR-T Market Size Market Share by Application (2019-2024)
Table 10. Global Cancer Drug based on CAR-T Revenue by Players (2019-2024) & ($ Millions)
Table 11. Global Cancer Drug based on CAR-T Revenue Market Share by Player (2019-2024)
Table 12. Cancer Drug based on CAR-T Key Players Head office and Products Offered
Table 13. Cancer Drug based on CAR-T Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Cancer Drug based on CAR-T Market Size by Regions 2019-2024 & ($ Millions)
Table 17. Global Cancer Drug based on CAR-T Market Size Market Share by Regions (2019-2024)
Table 18. Global Cancer Drug based on CAR-T Revenue by Country/Region (2019-2024) & ($ millions)
Table 19. Global Cancer Drug based on CAR-T Revenue Market Share by Country/Region (2019-2024)
Table 20. Americas Cancer Drug based on CAR-T Market Size by Country (2019-2024) & ($ Millions)
Table 21. Americas Cancer Drug based on CAR-T Market Size Market Share by Country (2019-2024)
Table 22. Americas Cancer Drug based on CAR-T Market Size by Type (2019-2024) & ($ Millions)
Table 23. Americas Cancer Drug based on CAR-T Market Size Market Share by Type (2019-2024)
Table 24. Americas Cancer Drug based on CAR-T Market Size by Application (2019-2024) & ($ Millions)
Table 25. Americas Cancer Drug based on CAR-T Market Size Market Share by Application (2019-2024)
Table 26. APAC Cancer Drug based on CAR-T Market Size by Region (2019-2024) & ($ Millions)
Table 27. APAC Cancer Drug based on CAR-T Market Size Market Share by Region (2019-2024)
Table 28. APAC Cancer Drug based on CAR-T Market Size by Type (2019-2024) & ($ Millions)
Table 29. APAC Cancer Drug based on CAR-T Market Size Market Share by Type (2019-2024)
Table 30. APAC Cancer Drug based on CAR-T Market Size by Application (2019-2024) & ($ Millions)
Table 31. APAC Cancer Drug based on CAR-T Market Size Market Share by Application (2019-2024)
Table 32. Europe Cancer Drug based on CAR-T Market Size by Country (2019-2024) & ($ Millions)
Table 33. Europe Cancer Drug based on CAR-T Market Size Market Share by Country (2019-2024)
Table 34. Europe Cancer Drug based on CAR-T Market Size by Type (2019-2024) & ($ Millions)
Table 35. Europe Cancer Drug based on CAR-T Market Size Market Share by Type (2019-2024)
Table 36. Europe Cancer Drug based on CAR-T Market Size by Application (2019-2024) & ($ Millions)
Table 37. Europe Cancer Drug based on CAR-T Market Size Market Share by Application (2019-2024)
Table 38. Middle East & Africa Cancer Drug based on CAR-T Market Size by Region (2019-2024) & ($ Millions)
Table 39. Middle East & Africa Cancer Drug based on CAR-T Market Size Market Share by Region (2019-2024)
Table 40. Middle East & Africa Cancer Drug based on CAR-T Market Size by Type (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Cancer Drug based on CAR-T Market Size Market Share by Type (2019-2024)
Table 42. Middle East & Africa Cancer Drug based on CAR-T Market Size by Application (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Cancer Drug based on CAR-T Market Size Market Share by Application (2019-2024)
Table 44. Key Market Drivers & Growth Opportunities of Cancer Drug based on CAR-T
Table 45. Key Market Challenges & Risks of Cancer Drug based on CAR-T
Table 46. Key Industry Trends of Cancer Drug based on CAR-T
Table 47. Global Cancer Drug based on CAR-T Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 48. Global Cancer Drug based on CAR-T Market Size Market Share Forecast by Regions (2025-2030)
Table 49. Global Cancer Drug based on CAR-T Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 50. Global Cancer Drug based on CAR-T Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 51. Fosun Kite Biotechnology Details, Company Type, Cancer Drug based on CAR-T Area Served and Its Competitors
Table 52. Fosun Kite Biotechnology Cancer Drug based on CAR-T Product Offered
Table 53. Fosun Kite Biotechnology Cancer Drug based on CAR-T Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 54. Fosun Kite Biotechnology Main Business
Table 55. Fosun Kite Biotechnology Latest Developments
Table 56. Gilead Sciences Details, Company Type, Cancer Drug based on CAR-T Area Served and Its Competitors
Table 57. Gilead Sciences Cancer Drug based on CAR-T Product Offered
Table 58. Gilead Sciences Main Business
Table 59. Gilead Sciences Cancer Drug based on CAR-T Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 60. Gilead Sciences Latest Developments
Table 61. Novartis Details, Company Type, Cancer Drug based on CAR-T Area Served and Its Competitors
Table 62. Novartis Cancer Drug based on CAR-T Product Offered
Table 63. Novartis Main Business
Table 64. Novartis Cancer Drug based on CAR-T Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 65. Novartis Latest Developments
Table 66. Bristol-Myers Squibb Details, Company Type, Cancer Drug based on CAR-T Area Served and Its Competitors
Table 67. Bristol-Myers Squibb Cancer Drug based on CAR-T Product Offered
Table 68. Bristol-Myers Squibb Main Business
Table 69. Bristol-Myers Squibb Cancer Drug based on CAR-T Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 70. Bristol-Myers Squibb Latest Developments
Table 1. Cancer Drug based on CAR-T Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Allogeneic
Table 3. Major Players of Autologous
Table 4. Cancer Drug based on CAR-T Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 5. Global Cancer Drug based on CAR-T Market Size by Type (2019-2024) & ($ Millions)
Table 6. Global Cancer Drug based on CAR-T Market Size Market Share by Type (2019-2024)
Table 7. Cancer Drug based on CAR-T Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global Cancer Drug based on CAR-T Market Size by Application (2019-2024) & ($ Millions)
Table 9. Global Cancer Drug based on CAR-T Market Size Market Share by Application (2019-2024)
Table 10. Global Cancer Drug based on CAR-T Revenue by Players (2019-2024) & ($ Millions)
Table 11. Global Cancer Drug based on CAR-T Revenue Market Share by Player (2019-2024)
Table 12. Cancer Drug based on CAR-T Key Players Head office and Products Offered
Table 13. Cancer Drug based on CAR-T Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Cancer Drug based on CAR-T Market Size by Regions 2019-2024 & ($ Millions)
Table 17. Global Cancer Drug based on CAR-T Market Size Market Share by Regions (2019-2024)
Table 18. Global Cancer Drug based on CAR-T Revenue by Country/Region (2019-2024) & ($ millions)
Table 19. Global Cancer Drug based on CAR-T Revenue Market Share by Country/Region (2019-2024)
Table 20. Americas Cancer Drug based on CAR-T Market Size by Country (2019-2024) & ($ Millions)
Table 21. Americas Cancer Drug based on CAR-T Market Size Market Share by Country (2019-2024)
Table 22. Americas Cancer Drug based on CAR-T Market Size by Type (2019-2024) & ($ Millions)
Table 23. Americas Cancer Drug based on CAR-T Market Size Market Share by Type (2019-2024)
Table 24. Americas Cancer Drug based on CAR-T Market Size by Application (2019-2024) & ($ Millions)
Table 25. Americas Cancer Drug based on CAR-T Market Size Market Share by Application (2019-2024)
Table 26. APAC Cancer Drug based on CAR-T Market Size by Region (2019-2024) & ($ Millions)
Table 27. APAC Cancer Drug based on CAR-T Market Size Market Share by Region (2019-2024)
Table 28. APAC Cancer Drug based on CAR-T Market Size by Type (2019-2024) & ($ Millions)
Table 29. APAC Cancer Drug based on CAR-T Market Size Market Share by Type (2019-2024)
Table 30. APAC Cancer Drug based on CAR-T Market Size by Application (2019-2024) & ($ Millions)
Table 31. APAC Cancer Drug based on CAR-T Market Size Market Share by Application (2019-2024)
Table 32. Europe Cancer Drug based on CAR-T Market Size by Country (2019-2024) & ($ Millions)
Table 33. Europe Cancer Drug based on CAR-T Market Size Market Share by Country (2019-2024)
Table 34. Europe Cancer Drug based on CAR-T Market Size by Type (2019-2024) & ($ Millions)
Table 35. Europe Cancer Drug based on CAR-T Market Size Market Share by Type (2019-2024)
Table 36. Europe Cancer Drug based on CAR-T Market Size by Application (2019-2024) & ($ Millions)
Table 37. Europe Cancer Drug based on CAR-T Market Size Market Share by Application (2019-2024)
Table 38. Middle East & Africa Cancer Drug based on CAR-T Market Size by Region (2019-2024) & ($ Millions)
Table 39. Middle East & Africa Cancer Drug based on CAR-T Market Size Market Share by Region (2019-2024)
Table 40. Middle East & Africa Cancer Drug based on CAR-T Market Size by Type (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Cancer Drug based on CAR-T Market Size Market Share by Type (2019-2024)
Table 42. Middle East & Africa Cancer Drug based on CAR-T Market Size by Application (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Cancer Drug based on CAR-T Market Size Market Share by Application (2019-2024)
Table 44. Key Market Drivers & Growth Opportunities of Cancer Drug based on CAR-T
Table 45. Key Market Challenges & Risks of Cancer Drug based on CAR-T
Table 46. Key Industry Trends of Cancer Drug based on CAR-T
Table 47. Global Cancer Drug based on CAR-T Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 48. Global Cancer Drug based on CAR-T Market Size Market Share Forecast by Regions (2025-2030)
Table 49. Global Cancer Drug based on CAR-T Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 50. Global Cancer Drug based on CAR-T Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 51. Fosun Kite Biotechnology Details, Company Type, Cancer Drug based on CAR-T Area Served and Its Competitors
Table 52. Fosun Kite Biotechnology Cancer Drug based on CAR-T Product Offered
Table 53. Fosun Kite Biotechnology Cancer Drug based on CAR-T Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 54. Fosun Kite Biotechnology Main Business
Table 55. Fosun Kite Biotechnology Latest Developments
Table 56. Gilead Sciences Details, Company Type, Cancer Drug based on CAR-T Area Served and Its Competitors
Table 57. Gilead Sciences Cancer Drug based on CAR-T Product Offered
Table 58. Gilead Sciences Main Business
Table 59. Gilead Sciences Cancer Drug based on CAR-T Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 60. Gilead Sciences Latest Developments
Table 61. Novartis Details, Company Type, Cancer Drug based on CAR-T Area Served and Its Competitors
Table 62. Novartis Cancer Drug based on CAR-T Product Offered
Table 63. Novartis Main Business
Table 64. Novartis Cancer Drug based on CAR-T Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 65. Novartis Latest Developments
Table 66. Bristol-Myers Squibb Details, Company Type, Cancer Drug based on CAR-T Area Served and Its Competitors
Table 67. Bristol-Myers Squibb Cancer Drug based on CAR-T Product Offered
Table 68. Bristol-Myers Squibb Main Business
Table 69. Bristol-Myers Squibb Cancer Drug based on CAR-T Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 70. Bristol-Myers Squibb Latest Developments
LIST OF FIGURES
Figure 1. Cancer Drug based on CAR-T Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Cancer Drug based on CAR-T Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Cancer Drug based on CAR-T Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Cancer Drug based on CAR-T Sales Market Share by Country/Region (2023)
Figure 8. Cancer Drug based on CAR-T Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Cancer Drug based on CAR-T Market Size Market Share by Type in 2023
Figure 10. Cancer Drug based on CAR-T in Hospital
Figure 11. Global Cancer Drug based on CAR-T Market: Hospital (2019-2024) & ($ Millions)
Figure 12. Cancer Drug based on CAR-T in Pharmacy
Figure 13. Global Cancer Drug based on CAR-T Market: Pharmacy (2019-2024) & ($ Millions)
Figure 14. Cancer Drug based on CAR-T in Other
Figure 15. Global Cancer Drug based on CAR-T Market: Other (2019-2024) & ($ Millions)
Figure 16. Global Cancer Drug based on CAR-T Market Size Market Share by Application in 2023
Figure 17. Global Cancer Drug based on CAR-T Revenue Market Share by Player in 2023
Figure 18. Global Cancer Drug based on CAR-T Market Size Market Share by Regions (2019-2024)
Figure 19. Americas Cancer Drug based on CAR-T Market Size 2019-2024 ($ Millions)
Figure 20. APAC Cancer Drug based on CAR-T Market Size 2019-2024 ($ Millions)
Figure 21. Europe Cancer Drug based on CAR-T Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa Cancer Drug based on CAR-T Market Size 2019-2024 ($ Millions)
Figure 23. Americas Cancer Drug based on CAR-T Value Market Share by Country in 2023
Figure 24. United States Cancer Drug based on CAR-T Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada Cancer Drug based on CAR-T Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico Cancer Drug based on CAR-T Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil Cancer Drug based on CAR-T Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC Cancer Drug based on CAR-T Market Size Market Share by Region in 2023
Figure 29. APAC Cancer Drug based on CAR-T Market Size Market Share by Type in 2023
Figure 30. APAC Cancer Drug based on CAR-T Market Size Market Share by Application in 2023
Figure 31. China Cancer Drug based on CAR-T Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan Cancer Drug based on CAR-T Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea Cancer Drug based on CAR-T Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia Cancer Drug based on CAR-T Market Size Growth 2019-2024 ($ Millions)
Figure 35. India Cancer Drug based on CAR-T Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia Cancer Drug based on CAR-T Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe Cancer Drug based on CAR-T Market Size Market Share by Country in 2023
Figure 38. Europe Cancer Drug based on CAR-T Market Size Market Share by Type (2019-2024)
Figure 39. Europe Cancer Drug based on CAR-T Market Size Market Share by Application (2019-2024)
Figure 40. Germany Cancer Drug based on CAR-T Market Size Growth 2019-2024 ($ Millions)
Figure 41. France Cancer Drug based on CAR-T Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK Cancer Drug based on CAR-T Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy Cancer Drug based on CAR-T Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia Cancer Drug based on CAR-T Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa Cancer Drug based on CAR-T Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Cancer Drug based on CAR-T Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Cancer Drug based on CAR-T Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Cancer Drug based on CAR-T Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa Cancer Drug based on CAR-T Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel Cancer Drug based on CAR-T Market Size Growth 2019-2024 ($ Millions)
Figure 51. Turkey Cancer Drug based on CAR-T Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country Cancer Drug based on CAR-T Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas Cancer Drug based on CAR-T Market Size 2025-2030 ($ Millions)
Figure 54. APAC Cancer Drug based on CAR-T Market Size 2025-2030 ($ Millions)
Figure 55. Europe Cancer Drug based on CAR-T Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa Cancer Drug based on CAR-T Market Size 2025-2030 ($ Millions)
Figure 57. United States Cancer Drug based on CAR-T Market Size 2025-2030 ($ Millions)
Figure 58. Canada Cancer Drug based on CAR-T Market Size 2025-2030 ($ Millions)
Figure 59. Mexico Cancer Drug based on CAR-T Market Size 2025-2030 ($ Millions)
Figure 60. Brazil Cancer Drug based on CAR-T Market Size 2025-2030 ($ Millions)
Figure 61. China Cancer Drug based on CAR-T Market Size 2025-2030 ($ Millions)
Figure 62. Japan Cancer Drug based on CAR-T Market Size 2025-2030 ($ Millions)
Figure 63. Korea Cancer Drug based on CAR-T Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia Cancer Drug based on CAR-T Market Size 2025-2030 ($ Millions)
Figure 65. India Cancer Drug based on CAR-T Market Size 2025-2030 ($ Millions)
Figure 66. Australia Cancer Drug based on CAR-T Market Size 2025-2030 ($ Millions)
Figure 67. Germany Cancer Drug based on CAR-T Market Size 2025-2030 ($ Millions)
Figure 68. France Cancer Drug based on CAR-T Market Size 2025-2030 ($ Millions)
Figure 69. UK Cancer Drug based on CAR-T Market Size 2025-2030 ($ Millions)
Figure 70. Italy Cancer Drug based on CAR-T Market Size 2025-2030 ($ Millions)
Figure 71. Russia Cancer Drug based on CAR-T Market Size 2025-2030 ($ Millions)
Figure 72. Spain Cancer Drug based on CAR-T Market Size 2025-2030 ($ Millions)
Figure 73. Egypt Cancer Drug based on CAR-T Market Size 2025-2030 ($ Millions)
Figure 74. South Africa Cancer Drug based on CAR-T Market Size 2025-2030 ($ Millions)
Figure 75. Israel Cancer Drug based on CAR-T Market Size 2025-2030 ($ Millions)
Figure 76. Turkey Cancer Drug based on CAR-T Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries Cancer Drug based on CAR-T Market Size 2025-2030 ($ Millions)
Figure 78. Global Cancer Drug based on CAR-T Market Size Market Share Forecast by Type (2025-2030)
Figure 79. Global Cancer Drug based on CAR-T Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Cancer Drug based on CAR-T Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Cancer Drug based on CAR-T Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Cancer Drug based on CAR-T Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Cancer Drug based on CAR-T Sales Market Share by Country/Region (2023)
Figure 8. Cancer Drug based on CAR-T Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Cancer Drug based on CAR-T Market Size Market Share by Type in 2023
Figure 10. Cancer Drug based on CAR-T in Hospital
Figure 11. Global Cancer Drug based on CAR-T Market: Hospital (2019-2024) & ($ Millions)
Figure 12. Cancer Drug based on CAR-T in Pharmacy
Figure 13. Global Cancer Drug based on CAR-T Market: Pharmacy (2019-2024) & ($ Millions)
Figure 14. Cancer Drug based on CAR-T in Other
Figure 15. Global Cancer Drug based on CAR-T Market: Other (2019-2024) & ($ Millions)
Figure 16. Global Cancer Drug based on CAR-T Market Size Market Share by Application in 2023
Figure 17. Global Cancer Drug based on CAR-T Revenue Market Share by Player in 2023
Figure 18. Global Cancer Drug based on CAR-T Market Size Market Share by Regions (2019-2024)
Figure 19. Americas Cancer Drug based on CAR-T Market Size 2019-2024 ($ Millions)
Figure 20. APAC Cancer Drug based on CAR-T Market Size 2019-2024 ($ Millions)
Figure 21. Europe Cancer Drug based on CAR-T Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa Cancer Drug based on CAR-T Market Size 2019-2024 ($ Millions)
Figure 23. Americas Cancer Drug based on CAR-T Value Market Share by Country in 2023
Figure 24. United States Cancer Drug based on CAR-T Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada Cancer Drug based on CAR-T Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico Cancer Drug based on CAR-T Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil Cancer Drug based on CAR-T Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC Cancer Drug based on CAR-T Market Size Market Share by Region in 2023
Figure 29. APAC Cancer Drug based on CAR-T Market Size Market Share by Type in 2023
Figure 30. APAC Cancer Drug based on CAR-T Market Size Market Share by Application in 2023
Figure 31. China Cancer Drug based on CAR-T Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan Cancer Drug based on CAR-T Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea Cancer Drug based on CAR-T Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia Cancer Drug based on CAR-T Market Size Growth 2019-2024 ($ Millions)
Figure 35. India Cancer Drug based on CAR-T Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia Cancer Drug based on CAR-T Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe Cancer Drug based on CAR-T Market Size Market Share by Country in 2023
Figure 38. Europe Cancer Drug based on CAR-T Market Size Market Share by Type (2019-2024)
Figure 39. Europe Cancer Drug based on CAR-T Market Size Market Share by Application (2019-2024)
Figure 40. Germany Cancer Drug based on CAR-T Market Size Growth 2019-2024 ($ Millions)
Figure 41. France Cancer Drug based on CAR-T Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK Cancer Drug based on CAR-T Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy Cancer Drug based on CAR-T Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia Cancer Drug based on CAR-T Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa Cancer Drug based on CAR-T Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Cancer Drug based on CAR-T Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Cancer Drug based on CAR-T Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Cancer Drug based on CAR-T Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa Cancer Drug based on CAR-T Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel Cancer Drug based on CAR-T Market Size Growth 2019-2024 ($ Millions)
Figure 51. Turkey Cancer Drug based on CAR-T Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country Cancer Drug based on CAR-T Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas Cancer Drug based on CAR-T Market Size 2025-2030 ($ Millions)
Figure 54. APAC Cancer Drug based on CAR-T Market Size 2025-2030 ($ Millions)
Figure 55. Europe Cancer Drug based on CAR-T Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa Cancer Drug based on CAR-T Market Size 2025-2030 ($ Millions)
Figure 57. United States Cancer Drug based on CAR-T Market Size 2025-2030 ($ Millions)
Figure 58. Canada Cancer Drug based on CAR-T Market Size 2025-2030 ($ Millions)
Figure 59. Mexico Cancer Drug based on CAR-T Market Size 2025-2030 ($ Millions)
Figure 60. Brazil Cancer Drug based on CAR-T Market Size 2025-2030 ($ Millions)
Figure 61. China Cancer Drug based on CAR-T Market Size 2025-2030 ($ Millions)
Figure 62. Japan Cancer Drug based on CAR-T Market Size 2025-2030 ($ Millions)
Figure 63. Korea Cancer Drug based on CAR-T Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia Cancer Drug based on CAR-T Market Size 2025-2030 ($ Millions)
Figure 65. India Cancer Drug based on CAR-T Market Size 2025-2030 ($ Millions)
Figure 66. Australia Cancer Drug based on CAR-T Market Size 2025-2030 ($ Millions)
Figure 67. Germany Cancer Drug based on CAR-T Market Size 2025-2030 ($ Millions)
Figure 68. France Cancer Drug based on CAR-T Market Size 2025-2030 ($ Millions)
Figure 69. UK Cancer Drug based on CAR-T Market Size 2025-2030 ($ Millions)
Figure 70. Italy Cancer Drug based on CAR-T Market Size 2025-2030 ($ Millions)
Figure 71. Russia Cancer Drug based on CAR-T Market Size 2025-2030 ($ Millions)
Figure 72. Spain Cancer Drug based on CAR-T Market Size 2025-2030 ($ Millions)
Figure 73. Egypt Cancer Drug based on CAR-T Market Size 2025-2030 ($ Millions)
Figure 74. South Africa Cancer Drug based on CAR-T Market Size 2025-2030 ($ Millions)
Figure 75. Israel Cancer Drug based on CAR-T Market Size 2025-2030 ($ Millions)
Figure 76. Turkey Cancer Drug based on CAR-T Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries Cancer Drug based on CAR-T Market Size 2025-2030 ($ Millions)
Figure 78. Global Cancer Drug based on CAR-T Market Size Market Share Forecast by Type (2025-2030)
Figure 79. Global Cancer Drug based on CAR-T Market Size Market Share Forecast by Application (2025-2030)
More Publications
Global White LED Dermatoscopes Market Growth 2024-2030
US$ 3,660.00
June 2024
115 pages
Global Portable Bagged Protein Powder Market Growth 2024-2030
US$ 3,660.00
October 2024
88 pages
Global Pediatric Pocket CPR Mask Market Growth 2023-2029
US$ 3,660.00
February 2023
113 pages
Global Medical Device Packaging Market Growth 2025-2031
US$ 3,660.00
December 2024
107 pages
Global Portable Electrosurgical Analyzer Market Growth 2023-2029
US$ 3,660.00
February 2023
77 pages
